Advertisement
Patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment
What's driving tumor progression is the key, says Nima Sharifi, MD
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement